Aspire Biopharma Holdings reported cash from operations of -$0.00B and free cash flow of -$0.00B for the quarter ended Jun 2026, down 85.5% year over year. This cash flow statement covers 22 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||
| Net Income | -0.00B | -0.00B | -0.02B | -0.00B | -0.00B | -0.01B | -0.00B | -0.00B | ||||||||||||||
| Share-based CompensationStock Comp. | 0.01B | 13.41B | 0.00B | |||||||||||||||||||
| Asset Writedowns and ImpairmentWritedown | 0.00B | |||||||||||||||||||||
| Cash from OperationsCash from Ops. | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | ||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 0.00B | 0.00B | 0.00B | 0.01B | 0.00B | |||||||||||||||||
| Change in Working Capital | ||||||||||||||||||||||
| Change in InventoryChange Inventory | 0.00B | 0.00B | -0.00B | |||||||||||||||||||
| Change in Account PayablesChange Payables | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | -0.00B | 0.00B | -0.00B | 0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | 0.00B | ||||
| Change in Accured ExpensesChange Accured Exp. | -0.00B | 0.00B | 0.00B | 0.00B | 0.00B | -0.00B | 0.00B | 0.00B | 0.00B | -0.00B | -0.00B | 0.00B | 0.00B | -0.00B | 0.00B | |||||||
| Investing Activities | ||||||||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | -0.29B | 0.00B | ||||||||||||||||||||
| Financing Activities | ||||||||||||||||||||||
| Other financing activitiesOther financing | 0.01B | 0.00B | -1.00 | |||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 0.00B | 0.00B | 0.30B | -0.00B | 0.00B | 0.00B | 0.00B | 0.00B | -0.00B | 0.00B | 0.00B | -0.00B | 0.01B | 0.01B | ||||||||
| Change in Capital Stock | ||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 0.00B | 0.00B | 0.01B | 0.01B | ||||||||||||||||||
| Additional items | ||||||||||||||||||||||
| Change in Cash | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -280.00 | 0.00B | -0.00B | -0.00B | -0.00B | 0.00B | -0.00B | 0.00B | -0.00B | 0.00B | 0.01B | ||||
| Free Cash FlowFCF | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | ||
| Net Cash FlowNCF | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -280.00 | 0.00B | -0.00B | -0.00B | -0.00B | 0.00B | -0.00B | 0.00B | -0.00B | 0.00B | 0.01B |